La medula ósea (MO) en la infección por el virus de la immunodeficiencia humana (VIH): La MO en la etiopatogenia de las alteraciones hematológicas asociadas a la infección por el VIH

Sangre

Volumn 41, Issue 3, 1996, Pages 221-230

  García, Marta Moreno ^a  

^a Hospital Penitenciario   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HEMOPOIETIC GROWTH FACTOR;

ANEMIA; ANIMAL; BLOOD; BONE MARROW; CAT; CAT DISEASE; CONNECTIVE TISSUE; CYTOPATHOGENIC EFFECT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUTROPENIA; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; THROMBOCYTOPENIA; VIROLOGY;

ANEMIA; ANIMALS; BONE MARROW; CATS; CONNECTIVE TISSUE; CYTOKINES; CYTOPATHOGENIC EFFECT, VIRAL; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; HEMATOPOIESIS; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELLS; HIV; HIV INFECTIONS; HUMANS; NEUTROPENIA; THROMBOCYTOPENIA;

EID: 0030170966     PISSN: 00364355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (167)

1. Roman A, Sánchez Fayos J, Olavarría E, Outeiriño J. Repercusiones hematológicas de la infección por el virus de la immunodeficiencia humana y su terapéutica. Sangre 1992; 37, 119-124.
2. Namiki TS, Boone DC, Meyer PR. A comparison of hone marrow findings in patients with acquired immunodeficiency sindrome (AIDS) and AIDS related conditions. Hematol Oncol 1987; 5: 99-103
3. Frontiera M, Myers AM. Peripheral blood and bone marrow abnormalities in the acquired immunodeficiency syndrome. West J Med 1987; 147: 157-160.
4. Fisher M, Tomlinson DR. Coker RJ, Claydon EJ. Fourth European Conference on Clinical aspects and Treatment of HIV infection. Milan 1994. Abstract P454.
5. Scadden DT, Zon LI, Groopman JE. Pathophysiology and management of HIV-associtated hematologic disorders. Blood 1989;74:1455-1450.
6. Boyar A, Beall G. HIV-seropositive thrombocytopenia: the action of zidovudine AIDS 1991; 5: 1351-1356.
7. Re MC, Furlini G, Zauli G, La Placa M. Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells. Arch Virol 1994; 137. 1-23.
8. Arock M, Dedenon A, Le Goff L, Michel A, Missenard G, Debre P, et al. Specific ligation of the HIV-1 viral envelope protein gp120 on CD34+ bone marrow-denved progenitors. Cell Mol Biol Noisy Le Grand 1994; 40: 319-323.
9. Ganser A. Abnormalities of hematopoiesis in acquired immunodeficiency syndrome. Blut 1988; 56:49.
10. Johnson A, Dorsh I. Stromal cells in myeloid and lymphoid long-term bone-marrow cultures can support hematopoiesis and modulate the production of hematopoietic growth factors. Blood 1986; 68: 1348-1354.
11. Lichtman M The ultrastructure of the hematopoietic environnent: a review. Exp Hematol 1981; 9: 391-410.
12. Wineman JP, Nishi SI, Muller-Sieburg CE. Maintenance of high levels of pluripotent hematopoietic stem cells in vitro: effects of stromal cells and c-kit. Blood 1993; 81: 365-372.
13. Liesch GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor (first of two parts). N Engl J Med 1992; 327: 28-35.
14. Steinberg HN, Crumpacker CS, Chatis PA. In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J Virol 1991; 65: 1765-1769.
15. Zauli G, Re MC, Furlini G. Giovannini M, La Placa M. Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells). J Gen Virol 1992; 73: 417-421.
16. Zauli G, Re MC. Visani G. Evidence for a human inmunodeficiency virus type 1 mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J Infect Dis 1992. 166: 710-716.
17. Stanley SK, Kessler SW, Justement JS, Schnittman SM, Greenhouse JJ, Brown CC, et al. CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol 1992; 149: 689-693.
18. Geissler RG, Ottmann OG, Kleiner K, Mentzel U, Bickelhaupt A, Hoelzer D, et al. Decreased haematopoietic colony growth in long-term bone marrow cultures of HIV-positive patients. Res Virol 1993; 144: 69-73.
19. Louache F, Henri A, Bettaieb A, Oksenhendler E, Raguin G, Tulliez M, et al. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 1992; 80: 2991-2997.
20. Stella CC, Ganser A, Hoelzer D. Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. J Clin Invest 1987; 80. 286-293.
21. Lunardi-Iskandar Y, Georgoulias V, Bertoli AM, Augery Bourget Y, Ammar A, Vittecoq D, et al. Impaired in vitro proliferation of hemopoietic precursors in HIV-1 infected subjects. Leuk Res 1989; 13: 573-579.
22. Bagnara GP, Zauli G, Giovannmi M, Re MC, Furlini G Early loss of circulating hematopoietic progenitors in HIV-1 infected subjects. Exp Hematol 1990; 18: 426-430.
23. Molina JM, Scadden DT, Sakaguchi M, Fuller B, Woon A, Groopman JE. Lack of evidence for infection of or effects on growth of hematopoietic progenitor cells in vivo or in vitro exposure to human immunodeficiency virus. Blood 1990; 76: 2476-2481.
24. De Luca A, Teofili L, Antironi A, Iovino MS, Mencarini P, Visconti E, et al. Haematopoietic CD34+ progenitor cells are not infected by HIV- in vivo but show impaired clonogenesis. Br J Haematol. 1993; 85 20-24.
25. Zauli G, Re MC, Davis B, Sen L, Visani G, Gugliotta L, et al. Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals Blood 1992; 79: 2680-2687.
26. Cen D, Zauli G, Szarnicki R, Davis BR. Effect of different human immunodeficiency virus type-1 (HIV-1) isolates on long term bone marrow haematopoiesis. Br J Haematol 1993; 85, 596-602.
27. Bagnara GP, Zauli G, Giovannini M, Re MC, Furlini G, La Placa M. Early loss of circulating hemopoietic progenitors in HIV-1 infected subjets. Exp Hematol 1990, 18: 426-431.
28. Ganser A, Ottmann OG, von Briesen H, Volkers B, Rubsamen H, Hoelzer D, et al. Changes in the haematopoietic progenitor cell compartment in the acquired immunodeficiency syndrome. Res Virol 1990; 141: 185-193.
29. von Laer D, Modrau B, Dietrich M, Kern P. Leukocyte differentiation antigens in the bone marrow of patients with HIV-related disease. Acta Haematol 1994; 92: 197-203.
30. Burstein Y, Rashbaum WK, Hatch WC, Calvelli T, Golodner M, Soeiro R, et al. Alteration in human fetal hematopoiesis are associated with maternal HIV infection. Pediatr Res 1992; 32: 155-159.
31. Linenberger ML, Beebe AM, Pedersen NC, Abkowitz JL, Dandekar S. Marrow accesory cell infection and alterations in hematopoiesis accompany severe neutropenia during experimental acute infection with feline immunodeficiency virus. Blood 1995; 85: 941-951.
32. Tindall B, Cooper DA. Primary HIV infection: Host responses and intervention strategies. AIDS 1991; 5, 1-3.
33. Daae ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus tipe 1 infection. N Engl J Med 1991; 324: 961-966.
34. Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, et al. High liters of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 1991; 324: 954-959.
35. Kinloch de Loes S, de Saussure P, Saurat JH, Stalder H, Hirschel B, Perrin LH. Symptomatic primary infection due to human immunodeficiency virus type 1 Review of 31 cases. Clin Infect Dis 1993; 17: 59-64.
36. Games II, von Sydow M, Pehrson PO, Lundbergh P. Clinical picture of primary HIV infection presenting as a glandular fever like illness Br Med J 1988; 297: 1363-1390.
37. Re MC, Zauli G, Gibellini D, Furlini G, Ramazzotti E, Monari P, et al. Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS 1993; 7: 1049-1055.
38. Zauli G, Vitale M, Re MC, Furlini G, Zamai L, Falcieri E, et al. In Vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell line Blood 1994; 83: 167-175.
39. Harbol AW, Liesveld JL, Simpson PJ, Abbound CN. Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev 1994; 8: 241-251.
40. Davis BR, Schwartz DH, Marx JC, Johnson CE, Berry JM, Lyding J, et al. Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J Virol 1991; 65: 1985-1992.
41. Hillyer CD, Lackey DA, Villinger F, Winton EF, McClure HM, Ansari AA, et al. CD34+ and CFU-GM progenitors are significantly decreased in SIV infected rhesus macaques with minimal evidence of direct viral infection by polimerase chain reaction. Am J Hematol 1993; 43: 274-278.
42. von Laer D, Hufert FT, Fenner TE, Schwander S, Dietrich M, Schmitz H, et al. CD34 + hematopoietic progenitors cells are not a major reservoir of the human immunodeficiency virus. Blood 1990; 76: 1281-1286.
43. Steinberg HN, Crumpac CS, Chatis PA. In vitro suppression of normal human bonemarrow progenitor cells by human immunodeficiency virus. J Virol 1991; 65: 1765-1769.
44. Folks TM, Kessler SW, Orenstein JM. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 1988; 242 919.
45. Kojouharoff G, Ottmann OG, von Briesen H, Geissler G, Rubsamen H, Hoelzer D, et al. Infection of granulocyte/monocyte progenitor cells with HIVI. Res Virol 1991; 142: 15 1157
46. Sun NCJ, Shapshak P, Lachant NA. Bone marrow examination in patients with AIDS and AIDS-related complex (ARC). Am J Clin Pathol 1989; 92: 589-594.
47. Busch M, Beckstead J, Gantz D, Vyas G. Detection of human immunodeficiency virus infection of mieloid precursors in bone marrow samples from AIDS. Blood 1986; 68 suppl 1: 122a.
48. Ushijima H, Dairaku M, Honma H, Yamaguchi K, Shimizu H, Tsuchie H, et al. Human immunodeficiency virus infection in cells of myeloid monocytic lineage. Microbiol Immunol 1991; 35: 487-492.
49. Zauli G, Furlini G, Vitale M, Re MC, Gibellini D, Zamai L, et al. A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus-type 1. Blood 1994; 84: 1896-1905.
50. Caux C, Favre C, Saeland S, Duvert V, Mannoni P, Durand I, et al. Sequential loss of CD34 and class II MHC antigens on purified cord blood hematopoietic progenitors cultured with IL-3: Characterization of CD34-, HLA-DR+cells. Blood 1989; 74: 1989-1995.
51. Zauli G, Re MC, Davis DR, Sen L, Visani G, Gugliotta L, et al. Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in HIV-1 seropositive thrombocytopenic individuals. Blood 1992; 79: 2680-2686.
52. Kouri YH, Borkowsky W, Nardi M, Karpatkin S, Basch RS. Human megakarocytes have a CD4 molecule capable of finding human immunodeficiency virus-1. Blood 1993; 81: 26642670
53. Sakaguchi M, Saato T, Groopman JE. Human immunodeficiency virus infection of megakaryocytic cells. Blood 1991, 77: 481-485.
54. Basch RS, Kouri YH, Karpatkin S Expression of CD4 by human megakaryocytes. Proc Natl Acad Sci USA 1990; 87: 8085-8089.
55. Zucker D, Sermetis S, Zheng ZY Internalization of human immunodeficiency virus type 1 and other retroviruses by megakariocytes and platelets. Blood 1990; 75: 1920-1923.
56. Zucker-Franklin D. Cao YZ. Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. Proc Natl Acad Sci USA 1989; 80: 5595-5599.
57. Louache F, Bettaieb A, Henri A. Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenic purpura. Blood 1991; 78: 1697-1705.
58. Peña JM, Arnalich F, Barbado FJ. Successful zidovudine therapy for HIV-related severe thrombocitopenia: report of a sustained remission. Acta Haematol 1990; 83: 86-88
59. Montaner JSG, Le T, Fanning M. The effect of zidovudine on platelet count in HIV infected indivi&als. J Acquir Immune Defic Syndr 1990; 3, 565-570.
60. Ballem PJ, Belzberg MD, Devine DV, Lyster D, Spruston B, Chambers RN, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1779-1794.
61. Canque B, Marandin A, Rosenzwajg M, Louache F, Vaincherker W, Gluckman JC, et al. Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV). Virology 1995, 208: 779-783.
62. Gendelman HE, Baca LM, Turpin JA. Interactions between interferon and the human immunodeficiency virus. J Exp Pathol. 1990; 553-567.
63. Orenstein JM. Ultrastructural pathology of human immunodeficiency virus infection. Ultrastruct Pathol 1992; 16: 179-210.
64. Gastella A, Croxson TS, Mildvan D, Sitt DH, Zalushy R. The bone marrow in AIDS: a histologic, hematologic and microbiologic study. Am J Clin Pathol 1985: 84: 425-4-32.
65. Merril JE, Oyanagi Y, Chen IS. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 1989; 63: 4404-4408.
66. Reuben JM, Goni B, Li S, Turbin J. Induction of cytokines in normal placental cells by the human immunodeficiency virus. Lymphokine Cytokine Res 1991; 10: 195-199.
67. Platzer E. Human hematopoictic growth factors. Eur J Haematol 1989; 42: 1-15.
68. Lunardi Y, Nugeyre MT, Georgoulias V, Barré F, Jasmin C, Chermann JC. Replication of the human immunodeficiency virus 1 and impaired diferentiation of the T cells after in vitro infection of bone marrow immature T cells. J Clin Invest 1989: 83: 610-615.
69. Scadden DT, Zeira M, Woon A, Wang Z, Schieve L, Ikeuchi K, et al. Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 1990: 76: 317-322.
70. Schwartz GN, Kessler SW, Rothwell SW, Burrell LM, Reid TJ, Meltzer MS, et al. Inhibitory effects of HIV-1-infected stromal cell layers on the production of myeloid progenitor cells in human long-term bone marrow cultures. Exp Hematol 1994; 22: 1288-1296.
71. Huang ZB, Potash MJ, Simm M, Shahabuddin M, Chao W, Gendelman HE, et al. Infection of macrophages with lymphotropic human immunodeficiency virus type 1 can be arrested after viral DNA synthesis. J Virol 1993; 67: 6893-6896.
72. McKeating JA, Griffith:, PD, Weiss RA. HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature 1990; 343: 659-661.
73. Blumberg N, Heal MJ. Transfusion and recipient immune function. Arch Pathol Lab Med 1989; 113: 246-253.
74. Hamburger AW, Chen RB. Impaired ability of bone marrow cells from immunodeficient mice to establish long-term cultures. Br J Haematol 1993; 85: 646-652.
75. Fol TM, Essler SW, Oreinstein JM, Justement JS, Jaffe ES, Fauci AS. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science. 1988; 242: 919-922.
76. Landsdrop PM. Subpopulation of cells that express CD34. Blood. 1989; 74: 13.
77. Zon LI, Groopman JE. Haematologic manifestations of the human immune deficiency virus (HIV) Semin Haematol 1988; 25: 208-218.
78. Scadden DT, Zeira M, Woon A. Human immunodeficiency infection of human bonemarrow stromal fibroblasts. Blood 1990; 76: 317-322.
79. Simmons PJ, Masinovs B, Longenec BM, Berenson R, Toro B, Gallatin WM. Vascular cell adhesion molecule-1 expresed by bone-marrow stromal cells. Blood 1992; 80: 388-395.
80. Steinber HN, Anderson J, Crumpacker CS, Chatis PA. HIVinfectionofBS-1 stromal cell line: effect on munne hematopoiesis Virology 1993, 193: 524-527.
81. Watanabe M, Ringler DJ, Nakamura M, DeLong PA, Letvin NL. Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth. J Virol 1990, 64: 656-663.
82. Balleari E, Timitilli S, Puppo F, Gaffuri L, Musselli C, Rizzo F, et al. Impaired in vitro growth of peripheral blood hematopoietic progenitor cells in HIV-infected patients, evidence of an inhibitory effect of autologous T lymphocytes. Ann Hematol 1991; 63: 320-325.
83. Maciejewski JP, Weichold FF, Young NS. HIV-suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J Immunol 1994; 153: 4303-4310.
84. Wiley EL, Nightingale SD. Oportunistic events and p17 expression in the bone marrow of human immunodeficiency virus-infected patients. J Infect Dis 1994; 169: 617-620.
85. Mandell CP, Jain NC, Miller CJ, Dandekar S. Bone marrow monocyte-macrophages are an early cellular target of pathogenic and nonpathogenic isolates of simian immunodeficiency virus (SIVmac) in rhesus macaques. Lab Invest 1995; 72: 323-333.
86. Calenda V, Graber P, Delamarter JF, Chermann JF. Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: in vitro study on bone marrow progenitor cells. Eur J Haematol 1994; 52: 103-107.
87. Donahue RE, Johnson MM, Zon LI, Groopman JE. In vitro supression of haematopoiesis after human immunodeficiency virus infection. Nature 1987; 326: 200-207.
88. Fuchs D, Zangerle R, Artner E, Weiss G, Fritsch P, Tilz GP et al Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur J Haematol 1993; 50: 90-94.
89. Calenda V, Sebahoun G, Chermann JC. Modulation of normal human erythropoietic progenitors cells in long term liquid cultures after HIV-1 infection. AIDS Res Hum Retroviruses 1992; 8: 61-67.
90. Calenda V, Chermann JC. The effects of HIV on hematopoiesis. Eur J Haematol 1992; 48: 181-186.
91. Leiderman IZ, Greenberg ML, Adelsberg BR, Siegal FP. A glicoprotein inhibitor of in vitro granulopoiesis associated with AIDS. Blood 1987: 70: 1267-1272.
92. Metcalf D. The molecular control of cell division, differentiation, commiment and maturation in haemopoietic cells. Nature 1989; 339: 27-30.
93. Molina JM, Scadden DT, Burn R, Dinarello CA, Groopman JE. Production of tumor necrosis factor alpha and interleukm 1 beta by monocitic cells infected with human immunodeficiency virus. J Clin Invest 1989; 84: 733-739.
94. Fibbe WE, Willems R. The role of interleukin-1 in haematopoiesis. Acta Haematol 1991; 86: 148-154.
95. Maury CP, Lahdevirta J. Correlation of serum cytokine levels with haematological abnormalities in human immunodeficiency virus infection. J Intern Med 1990; 227: 253-257
96. Ketlinskii SA, Kalinina NM, Tsvetkova SN, Rakhmanova AG, Maslov VN, Khaldeeva NA, et al. Tumornecrosisfactor-alpha and interleukin-beta in the blood plasma of patients with HIV infection. Vestn Ross Akad Med Nauk 1992; 9-10: 36-41. Abstract.
97. Herbein G, Keshav S, Collin M, Montaner LJ, Gordon S. HIV-1 induces tumor necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection. Clin Exp Immunol 1994; 95. 442-449.
98. Branch MA, Hermann F Hematopoietic growth factors. Interactions and regulation of production. Acta Haematol 1991; 86: 128-137.
99. Rabb RJ, Munk A, Smith. T-cell growth factor receptors: quantitation, specificity and biological relevance. J Exp Med 1981; 154: 1455-1474.
100. Hofmann B, Nishanian P, Fahey JL, Esmail I, Jackson AL, Deteis R, Cumberland W. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV-1 infection: distinctive parameters of HIV-1 induced changes. Clin Immunol Immunopathol 1991; 61: 212-224.
101. Honda M, Kitamura K, Matsuda K, Yokoda Y, Yamamoto N, Mitsuyasu R, et al Soluble IL-2 receptor in AIDS: correlation of its serum level with the classification of HIV induced disease and its characterization. J Immunol 1989; 142: 4248-4255.
102. Price HE, Kleinman S, Williams AE. Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV-1. J Immunol 1988; 140: 1139-1141
103. Westendorp MO, Li-Weber M, Frank RW. Human immunodeficiency virus type 1 tat upregulates interleukin-2 secretion in activated T cells. J Virol 1994; 68: 4177-4185.
104. Ribas M, Ribas A, Gale RP. Uso clínico de los factures de crecimiento hematopoyéticos (hemopoyetinas). Med Clin (Bare). 1993; 100: 707-711
105. Kitano K, Abboud CN, Ryan DH, Quan SG, Baldwin GC, Golde DW. Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood 1991; 77: 1699-705.
106. Naif H, Ho Shon M, Chang J, Cunningham AL. Molecular mechanisms of IL-4 effects on HIV expression in promonocytic cell lines and primary human monocytes. J Leukoc Biol 1994; 56, 335-339.
107. Schwartz GN, Kessler SW, Szabo JM, Burrell LM, Francis ML. Negative regulators may mediate some of the inhibitory effects of HIV- 3 infected stromal cell layers on erythropoiesis and myelopoiesis in human bone marrow long term cultures. J Leukoc Biol 1995; 57: 948-55
108. von Sydow M, Sonnerborg A, Games H, Strannegard O. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of VIH infection. AIDS Res Hum Retroviruses 1991; 7: 375-380.
109. Rosenberg ZF, Fauci AS. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expresion. Immunol Today 1990; 11: 176-180.
110. Collart MA, Belin D, Vassalli JD, de Ossodo S, Vassalli P. Gamma interferonenhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controled by short-lived repressers. J Exp Med 1986: 164: 2113-2118.
111. Francis ML, Meltzer MS, Gendelman HE. Interferons in the persistence, pathogenesis, and treatment of HIV infection. AIDS. Res Hum Retroviruses 1991; 8: 199-207.
112. Mitsuyasu RT. The potential role of alpha Interferon in the treatment of HIV infection. Publ of SEISIDA 1991; 2: 119-120.
113. Caruso A, Gonzalez R, Stellini R, Scalzini A, Peroni L, Turano, A, et al. Interferongamma marks activated T lymphocytes in AIDS patients. AIDS Res Hum Retroviruses 1990: 6, 899-904.
114. Gendelman HE, Bac LM, Kubrak JA, Turpin JA, Silverman R, Friedman R, et al. Lymphokin role in AIDS Pub of SEISIDA 1991: 3: 93-94.
115. Lane HC. The role of alpha-interferon in patients with human immunodeficiency virus infection. Semin Oncol 1991; 18: 46-52.
116. Alvarez de Mon. Interferon. Publ Of SEISIDA. 1991; 2: 17.
117. Ocan̈a I. Tratamiento del sarcoma de Kaposi asociado a sida con interferón-alfa. Pub Of SEISIDA 1991; 2: 111-112.
118. Groopman J. AIDS-related Kaposi's sarcoma: therapeutic modalities. Sem Hematol 1987; 24. 5-8
119. Gelman E, Preeble O, Steis R. Human lymphoblastoid Interferon treatment of Kaposi's sarcoma in the AIDS. Ann Intern Med 1984; 100: 671-6.
120. Geissler RG, Ottmann OC, Kojouharoff G, Reutzel P, Eder M, Hoelzer, D, et al. Influence of human recombinant interferon-alpha and interferon-gamma on bone marrow progenitors cells of HIV-positive individuals. AIDS Res Hum Retroviruses 1992; 8: 521-525.
121. Rosenthal GJ, Stranahan RP, Thompson M, Blair P, Germolec DR, Comment CE, et al Organ specific hematopoietic changes induced by a recombinant human interferon-alpha in mice. Fundam Appl Toxicol 1990; 14: 666-675.
122. Grunfeld C, Kotler DP, Shigenaga JK, Doerrler W, Tierney A, Wang J, et al. Circulating interferon-alpha levels and hypermgliceridemia in the acquired immunodeficiency syndrome Am J Med 1991; 90: 154-162.
123. Constans J, Pellegrin JL, Pellegrin I, Peuchant E, Dumon MF, Sergeant C, et al. Interferon and blood tumor necrosis factor in 95 patients with HIV infection. Rev Med Inter 1993; 14: 1004.
124. Lahdevirta TA, Maury CP, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 289-291.
125. Reddy MM, Sorrell SJ, Lange M, Grieco MH Tumor necrosis factor and HIV p24 antigen levels in serum of HIV infected populations. J Acquired Immune Defic Syndr 1988; 1: 436-440.
126. Roux-Lombard P, Mondoux C, Cruchaud A, Dayer JM Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1. Clin Immunol Immunopathol 1989; 50: 374-384.
127. Wright SC, Jewett R, Mitsuyasu R, Bonavida B. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol 1988; 141: 99-104.
128. Kruse A, Rieneck K, Kappel M Pentoxifilme therapy in HIV elevated tumor necrosis factor. Fifth European Conference on Clinical aspects and treatment of HIV infection. Copenhagen 1995. Abstract 537.
129. Suttmann U, Selberg O, Gallati H, Ockenga J, Deicher H, Muller MJ, et al. Tumour necrosis factor receptor levels are linked to the acute-phase response and malnutrition in human immunodeficiency virus infected patients. Clin Sci Colch 1994; 86: 461-467.
130. Aukrust P, Liabak NB, Muller F, Espevik T, Froland SS. Activation of tumor necrosis factor-alpha system in HIV-1 infection: association with markers of immune activation. Infection 1995; 23: 9-15.
131. Geissler RG, Ottmann OG, Eder M, Kojouharoff G, Hoelzer D. Effect of recombinant human transforming growth factor beta and tumor necrosis factor alpha on bone marrow progenitor cells of HIV-infected persons. Ann Hematol 1991; 62: 151-155
132. Fuchs D, Shearer GM, Boswell RN, Lucey DR, Clerici M, Reibnegger G, et al. Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection. AIDS 1991; 5: 209-12.
133. Mintz M, Rapaport R, Oleske JM, Conner EM, Koenigsberger MR, Denny T, et al. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am J Dis Child 1989; 143: 771-774
134. E Ow J, Wachman W, McCutchan JA, Cronin JA, Carson DA, et al Transforming growth factor beta and non-cytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc Natl Acad Sci USA. 1990; 87: 8321-8325.
135. Tsoukas CM, Bernard NF. Markers Predicting Progression of Human immunideficiency Virus-Related Disease. Clin Microbiol Rev 1994: 14-28.
136. Zauli G, Davis BR, ReMC, Visani G, Furlini G. Tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic supression. Blood 1992; 80: 3036-3043.
137. Axelrod AA. Some hematopoietic negative regulators. Exp Hematol 1990; 18: 143-150.
138. Harms B, Kogler G, Wernet P, Bruster HT, Schneider EM. Modulation of hemalopoietic colony formation of stem cells in periferal blood by anti-TGF-beta in patients with severe immunosuppression.Klin Wochenschr 1990; 69: 1139-1145. Abstract
139. Watari K, Asano S, Shirafuji N. Serum granulocyte colony stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzime immunoassay. Blood 1989; 73: 117-122.
140. Layton JE, Cebon JS, Morstyn G. Cytokine responses to febrile neutropenia. Exp Hematol 1991; 19: 506
141. Watari K, Asano S, Shirafuji N. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzime immunoassay. Blood 1989; 73: 117-122.
142. Kawacami M, Tsutsumi H, Kumakawa T. Levels of serum granulocyte colonystimulating factor in patients with infections. Blood 1990; 76: 1962-1964.
143. Mauss S, Steinmetz T, Willers R, Jablonowski H, Haussinger D. Induction of G-CSF by acute febrile infection but not by neutropenia in HIV seropositive individuals. A causal role for G-CSF in HIV-associated neutropenia. In: The Fifth European Conference on clinical aspects and treatment of HIV infection. Copenhagen-Denmark 1995. Abstract.541.
144. Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987; 326: 403-405.
145. Mauss S, Steinmetz HT, Armbrecht C, Kajala L, Jablonowski H, Haussinger D, et al. GM-CSF levels in HIV seropositive individuals. In: The fifth European conference on clinical aspects and treatment on HIV infection. Copenhagen-Denmark. 1995; Abstract 538.
146. Grant SM, Heel RC. Recombinant granulocyte macrophage colony stimulating factor (r GM-CSF). A review of its pharmacological properties and prospective role in the management of myelosuppresion. Drugs 1992; 43: 516-560
147. Hermans P, Rozenbaum W, Jou A, Castelli F, Borleffs J, Gray S, et al. Filgastrim (rmet-G-CSF) to treat neutropenia and support myelosuppresive medication dosing in HIV infection. En: The Fifth European Conference on Clinical Aspects and Treatment of HIV infection. Copenhagen-Denmark. 1995; Abstract 540.
148. Bergamini A, Perno CF, Dini L, Capozzi M, Pesce CD, Ventura L, et al. Macrophage colony-stimulating factor enhances the susceptibility of macrophages to infection by human immunodeficiency virus and reduces the activity of compounds that inhibit virus binding Blood 1994; 84: 3405-3412.
149. Pluda JM, Yarchoan R, Smith PD Subcutaneous recombinant granulocyte-macrophage colony stimulating factor used as a single agent and in an alternating regimen with azidithymidine in leukopenic patients with severe human immunodeficiency virus infection. Blood 1990; 76: 463-472.
150. Lieschke JL, Burgess AW. Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor (two parts). N Engl J Med 1992; 327: 28-35 y 99106.
151. Miles SA, Lee K, Hutlin L, Zsebo KM, Mitsuyasu RT. Potentiahiseofhumanstemcell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias. Blood 1991; 78: 3200-3208.
152. Manegold C, Jablonowski H, Armbrecht C, Strohmeyer G, Pietsch T. Serum levels of stem cell factor are increased in asymptomatic human immunodeficiency virus-infected patients and are associated with prolonged survival. Blood 1995; 86: 243-249.
153. Ascensao JL, Bilgrami S, Zanjani ED. Erythropoietin. Biology and clinical applications. Am J Pediatr Hematol Oncol 1991; 13: 376-387.
154. Abels RI, Rudnick SA. Erythropoietin: envolving clinical applications. Exp Hematol. 1991; 19: 842-850.
155. Ascensao JL, Bilgrami S, Zanjani ED. Erythropoietin. Biology and clinical applications. Am J Pediatr Hematol Oncol 1991; 13: 376-387.
156. Nissenson AR. Erythropoietin overview. Blood Purif. 1994; 12: 6-13
157. Geissler RG, Ganser A, Ottmann OG, Morawetz A, Guba P, Helm EB, et al. In vitro improvement of bone marrow-derived hematopoietic colony formation in HIV-positive patients by alpha-D-tocopherol and erythropoietin. Eur J Haematol 1994; 53: 201-206.
158. Gonzalez Lahoz J, Gazapo E, Martinez Blanco ML, Adrados M. Anemia en pacientes tratados con ZDV. Publ of SEISLDA. 1991; 2: 111.
159. Krantz SB. Erythropoietin and the anaemia of chromic disease. Nephrol Dial Transplant. 1995; 10: 10-17.
160. DeMarchi S, Pirisi M, Ferraccioli GF. Erythropoietin and the anemia of chronic diseases. Clin Exp Rheumatol 1993; 11: 429-444.
161. Markham A, Bryson HM, Epoietin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications Drags 1995; 49: 232-254.
162. Camacho J, Poveda F, Zamorano AF, Valencia ME, Vazquez JJ, Arnalich F, et al. Serum erythropoietin levels in anaemic patients with advanced human immunodeficiency virus infection. Br J Haematol 1992; 82: 608-614.
163. Wang Z, Goldberg MA, Scadden DT. HIV-1 suppresses erythropoietin production in vitro. Exp Hematol 1993; 21: 683-688.
164. Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 1989; 261: 3104-3107.
165. Henry DH, Bcall GN, Benson CA, Carcy J, Cone LA, Eron LJ, et al. Recombinant human erithropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Ann Intern Med 1992; 117: 739-748.
166. Rarick MU, Loureiro C, Groshen S, Sullivan J, Gill PS, Bernstein M, et al. Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia. J Acquir Immune Defic Syndr 1991; 4: 593-597.
167. Henry DH, Beall GN, Benson CA. Recombinan human erythropoietin in the treatment of anemia associated with human immune deficiency (HIV) infection with zidovudine therapy. Ann Intern Med 1992; 117: 739-748.